Real-world experience of Teduglutide use in adults with short bowel syndrome: A seven-year international multicenter survey.

Background And Aim: Teduglutide is a glucagon-like peptide-2 analogue used to promote intestinal rehabilitation and decrease the dependence from intravenous supplementation (IVS) in patients with short bowel syndrome and intestinal failure (SBS-IF). The aim of this study was to gain a better understanding of international real-world Teduglutide use since its launch.

Methods: Data from an international multicenter database for chronic IF were analysed.